Browsing by Author "Sharlaa Badal-Faesen"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item Extensive cervical lesion and treatment outcomes in women with HIVHPV coinfection(BIOMED CENTRAL LTD) R Mngqibisa; H Chen; Catherine Godfrey; M Sebitloane; Sharlaa Badal-Faesen; E et alItem Safety effectiveness and immunogenicity of heterologous mRNA1273 boost after prime with Ad26COV2S among healthcare workers in South Africa The singlearm openlabel phase 3 SHERPA studyN Garrett; T Reddy; N Yende-Zuma; A Takalani; Simone Richardson; Thandeka Moyo-Gwete; Sharlaa Badal-Faesen; Faeezah Patel; E et alItem A Standardized Approach for Collection of Objective Data to Support Outcome Determination for LatePhase Tuberculosis Clinical Trials(AMER THORACIC SOC) Ekaterina V. Kurbatova; Patrick P.J. Phillips; Susan E. Dorman; Erin E. Sizemore; E et al; Sharlaa Badal-Faesen; Ziyaad WajaItem Thirdline antiretroviral therapy including raltegravir RAL darunavir DRVr andor etravirine ETR is well tolerated and achieves durable virologic suppression over 144 weeks in resourcelimited settings ACTG A5288 strategy trialAnchalee Avihingsanon; Michael D. Hughes; Robert Salata; Catherine Godfrey; Sharlaa Badal-Faesen; Lerato Mohapi; E et al